Total Payments
$18,663
2024 Payments
$1,878
Companies
11
Transactions
61
Medicare Patients
275
Medicare Billing
$49,923
Payment Breakdown by Category
Consulting$11,018 (59.0%)
Travel$2,912 (15.6%)
Research$2,815 (15.1%)
Food & Beverage$1,846 (9.9%)
Education$64.50 (0.3%)
Gifts$8.74 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,018 | 5 | 59.0% |
| Travel and Lodging | $2,912 | 11 | 15.6% |
| Unspecified | $2,815 | 15 | 15.1% |
| Food and Beverage | $1,846 | 28 | 9.9% |
| Education | $64.50 | 1 | 0.3% |
| Gift | $8.74 | 1 | 0.0% |
Payments by Type
General
$15,848
46 transactions
Research
$2,815
15 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $10,735 | 5 | $0 (2024) |
| EMD Serono, Inc. | $1,757 | 13 | $0 (2019) |
| INTUITIVE SURGICAL, INC. | $1,408 | 12 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $1,229 | 9 | $0 (2019) |
| Clovis Oncology, Inc. | $1,123 | 7 | $0 (2018) |
| F. Hoffmann-La Roche AG | $1,057 | 2 | $0 (2021) |
| GlaxoSmithKline, LLC. | $497.25 | 7 | $0 (2024) |
| TESARO, Inc. | $400.00 | 1 | $0 (2018) |
| Karyopharm Therapeutics Inc. | $263.02 | 3 | $0 (2024) |
| Eisai Inc. | $117.78 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,878 | 17 | INTUITIVE SURGICAL, INC. ($1,315) |
| 2023 | $5,057 | 6 | AstraZeneca Pharmaceuticals LP ($4,795) |
| 2022 | $338.36 | 4 | GlaxoSmithKline, LLC. ($263.74) |
| 2021 | $3,455 | 3 | AstraZeneca Pharmaceuticals LP ($2,398) |
| 2020 | $3,425 | 1 | AstraZeneca Pharmaceuticals LP ($3,425) |
| 2019 | $2,987 | 22 | EMD Serono, Inc. ($1,757) |
| 2018 | $1,523 | 8 | Clovis Oncology, Inc. ($1,123) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: SURGERY | ||||||
| 10/16/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $102.98 | General |
| Category: Oncology | ||||||
| 09/09/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Education | In-kind items and services | $64.50 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $117.78 | General |
| Category: Oncology | ||||||
| 07/10/2024 | INTUITIVE SURGICAL, INC. | DA VINCI SP (Device) | Travel and Lodging | Cash or cash equivalent | $426.20 | General |
| Category: SURGERY | ||||||
| 07/10/2024 | INTUITIVE SURGICAL, INC. | DA VINCI SP (Device) | Travel and Lodging | Cash or cash equivalent | $85.15 | General |
| Category: SURGERY | ||||||
| 07/02/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $90.60 | General |
| Category: SURGERY | ||||||
| 07/02/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: SURGERY | ||||||
| 06/18/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: SURGERY | ||||||
| 05/21/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: SURGERY | ||||||
| 04/10/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $318.85 | General |
| Category: SURGERY | ||||||
| 04/10/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Gift | In-kind items and services | $8.74 | General |
| Category: SURGERY | ||||||
| 03/21/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $117.78 | General |
| Category: Oncology | ||||||
| 03/09/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Oncology | ||||||
| 03/08/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $136.08 | General |
| Category: Oncology | ||||||
| 02/02/2024 | INTUITIVE SURGICAL, INC. | DA VINCI SP (Device) | Travel and Lodging | Cash or cash equivalent | $229.79 | General |
| Category: SURGERY | ||||||
| 02/02/2024 | INTUITIVE SURGICAL, INC. | DA VINCI SP (Device) | Travel and Lodging | Cash or cash equivalent | $77.52 | General |
| Category: SURGERY | ||||||
| 11/17/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,740.00 | General |
| 11/15/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,055.00 | General |
| 11/04/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $41.08 | General |
| 10/25/2023 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $120.48 | General |
| Category: ONCOLOGY | ||||||
| 05/24/2023 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: ONCOLOGY | ||||||
| 03/28/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $93.34 | General |
| Category: SURGERY | ||||||
| 10/06/2022 | Seagen Inc. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $74.62 | General |
| Category: Oncology | ||||||
| 09/29/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $37.23 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| MS201943-0029 | EMD Serono, Inc. | $1,757 | 13 |
| A PHASE III, MULTICENTER, RANDOMIZED, STUDY OF ATEZOLIZUMAB VERSUS PLACEBO ADMINISTERED IN COMBINATION WITH PACLITAXEL, CARBOPLATIN, AND BEVACIZUMAB TO PATIENTS WITH NEWLY-DIAGNOSED STAGE III OR STAGE IV OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER | F. Hoffmann-La Roche AG | $1,057 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 45 | 83 | $34,821 | $8,092 |
| 2022 | 2 | 34 | 82 | $32,295 | $7,756 |
| 2021 | 2 | 34 | 60 | $31,480 | $7,756 |
| 2020 | 7 | 162 | 195 | $89,816 | $26,319 |
Total Patients
275
Total Services
420
Medicare Billing
$49,923
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 45 | $14,625 | $3,424 | 23.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 14 | 22 | $10,516 | $2,458 | 23.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 16 | 16 | $9,680 | $2,211 | 22.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 14 | 37 | $17,760 | $4,299 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 20 | 45 | $14,535 | $3,457 | 23.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 14 | 40 | $19,320 | $4,767 | 24.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 20 | 20 | $12,160 | $2,989 | 24.6% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2020 | 15 | 15 | $36,966 | $11,067 | 29.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 30 | 30 | $9,810 | $4,057 | 41.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 68 | $11,391 | $3,627 | 31.8% |
| 38570 | Removal of abdominal cavity lymph nodes using an endoscope | Facility | 2020 | 13 | 13 | $14,950 | $2,694 | 18.0% |
| 38900 | Lymph node imaging during surgery | Facility | 2020 | 16 | 16 | $8,316 | $2,441 | 29.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 13 | 18 | $3,870 | $1,495 | 38.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 35 | $4,513 | $938.08 | 20.8% |
About Dr. Christopher Darus, MD
Dr. Christopher Darus, MD is a Obstetrics & Gynecology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912026600.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Darus, MD has received a total of $18,663 in payments from pharmaceutical and medical device companies, with $1,878 received in 2024. These payments were reported across 61 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($11,018).
As a Medicare-enrolled provider, Darus has provided services to 275 Medicare beneficiaries, totaling 420 services with total Medicare billing of $49,923. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Obstetrics & Gynecology, Gynecologic Oncology
- Location Portland, OR
- Active Since 03/27/2007
- Last Updated 03/09/2021
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1912026600
Products in Payments
- LYNPARZA (Drug) $5,823
- Bavencio (Biological) $1,757
- LENVIMA (Drug) $1,229
- Rubraca (Drug) $1,123
- TECENTRIQ (Biological) $1,057
- DA VINCI SP (Device) $818.66
- ZEJULA (Drug) $698.46
- Da Vinci Surgical System (Device) $589.47
- XPOVIO (Drug) $263.02
- JEMPERLI (Biological) $120.48
- ENHERTU (Biological) $117.78
- Lenvima (Drug) $117.78
- TIVDAK (Biological) $74.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Portland
Amanda Clark, Md, MD
Obstetrics & Gynecology — Payments: $63,099
Obstetrics & Gynecology $63,099
Jeffrey Jensen, Md, MD
Obstetrics & Gynecology — Payments: $46,937
Obstetrics & Gynecology $46,937
Dr. Maria Rodriguez, Md, MD
Obstetrics & Gynecology — Payments: $34,515
Obstetrics & Gynecology $34,515
Shanti Mohling, Md, MD
Obstetrics & Gynecology — Payments: $29,352
Obstetrics & Gynecology $29,352
Lisa Bayer, M.d, M.D
Obstetrics & Gynecology — Payments: $27,827
Obstetrics & Gynecology $27,827
Dr. Jonathan Cook, Md, MD
Obstetrics & Gynecology — Payments: $9,217
Obstetrics & Gynecology $9,217